These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30261521)

  • 1. Diagnostic Single Gene Analyses Beyond Sanger.
    Najm J; Rath M; Schröder W; Felbor U
    Hamostaseologie; 2018 Aug; 38(3):158-165. PubMed ID: 30261521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disorders.
    Bastida JM; Del Rey M; Lozano ML; Sarasquete ME; Benito R; Fontecha ME; Fisac R; García-Frade LJ; Aguilar C; Martínez MP; Pardal E; Aguilera C; Pérez B; Ramos R; Cardesa MR; Martin-Antorán JM; Silvestre LA; Cebeira MJ; Bermejo N; Riesco S; Mendoza MC; García-Sanz R; González-Díaz M; Hernández-Rivas JM; González-Porras JR
    Haemophilia; 2016 Jul; 22(4):590-7. PubMed ID: 26879396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical validation of targeted next-generation sequencing for inherited disorders.
    Yohe S; Hauge A; Bunjer K; Kemmer T; Bower M; Schomaker M; Onsongo G; Wilson J; Erdmann J; Zhou Y; Deshpande A; Spears MD; Beckman K; Silverstein KA; Thyagarajan B
    Arch Pathol Lab Med; 2015 Feb; 139(2):204-10. PubMed ID: 25611102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABO genotyping with next-generation sequencing to resolve heterogeneity in donors with serology discrepancies.
    Wu PC; Lin YH; Tsai LF; Chen MH; Chen PL; Pai SC
    Transfusion; 2018 Sep; 58(9):2232-2242. PubMed ID: 29770457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.
    Schenkel LC; Kerkhof J; Stuart A; Reilly J; Eng B; Woodside C; Levstik A; Howlett CJ; Rupar AC; Knoll JHM; Ainsworth P; Waye JS; Sadikovic B
    J Mol Diagn; 2016 Sep; 18(5):657-667. PubMed ID: 27376475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confirming Variants in Next-Generation Sequencing Panel Testing by Sanger Sequencing.
    Baudhuin LM; Lagerstedt SA; Klee EW; Fadra N; Oglesbee D; Ferber MJ
    J Mol Diagn; 2015 Jul; 17(4):456-61. PubMed ID: 25960255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid Low-Cost Microarray-Based Genotyping for Genetic Screening in Primary Immunodeficiency.
    Suratannon N; van Wijck RTA; Broer L; Xue L; van Meurs JBJ; Barendregt BH; van der Burg M; Dik WA; Chatchatee P; Langerak AW; Swagemakers SMA; Goos JAC; Mathijssen IMJ; Dalm VASH; Suphapeetiporn K; Heezen KC; Drabwell J; Uitterlinden AG; van der Spek PJ; van Hagen PM;
    Front Immunol; 2020; 11():614. PubMed ID: 32373116
    [No Abstract]   [Full Text] [Related]  

  • 8. High-throughput sequencing of the entire genomic regions of CCM1/KRIT1, CCM2 and CCM3/PDCD10 to search for pathogenic deep-intronic splice mutations in cerebral cavernous malformations.
    Rath M; Jenssen SE; Schwefel K; Spiegler S; Kleimeier D; Sperling C; Kaderali L; Felbor U
    Eur J Med Genet; 2017 Sep; 60(9):479-484. PubMed ID: 28645800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Ion Torrent PGM sequencing workflow for the routine rapid detection of BRCA1 and BRCA2 germline mutations.
    Zanella I; Merola F; Biasiotto G; Archetti S; Spinelli E; Di Lorenzo D
    Exp Mol Pathol; 2017 Apr; 102(2):314-320. PubMed ID: 28263838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next-Generation Sequencing Panel Testing.
    Mu W; Lu HM; Chen J; Li S; Elliott AM
    J Mol Diagn; 2016 Nov; 18(6):923-932. PubMed ID: 27720647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translating sanger-based routine DNA diagnostics into generic massive parallel ion semiconductor sequencing.
    Diekstra A; Bosgoed E; Rikken A; van Lier B; Kamsteeg EJ; Tychon M; Derks RC; van Soest RA; Mensenkamp AR; Scheffer H; Neveling K; Nelen MR
    Clin Chem; 2015 Jan; 61(1):154-62. PubMed ID: 25274553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Phenotype-Genotype Correlations of Restrictive Cardiomyopathy With Myosin-Binding Protein C (MYBPC3) Gene Mutations Tested by Next-Generation Sequencing.
    Wu W; Lu CX; Wang YN; Liu F; Chen W; Liu YT; Han YC; Cao J; Zhang SY; Zhang X
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26163040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized diagnosis and management of congenital cataract by next-generation sequencing.
    Gillespie RL; O'Sullivan J; Ashworth J; Bhaskar S; Williams S; Biswas S; Kehdi E; Ramsden SC; Clayton-Smith J; Black GC; Lloyd IC
    Ophthalmology; 2014 Nov; 121(11):2124-37.e1-2. PubMed ID: 25148791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive mutation analysis for congenital muscular dystrophy: a clinical PCR-based enrichment and next-generation sequencing panel.
    Valencia CA; Ankala A; Rhodenizer D; Bhide S; Littlejohn MR; Keong LM; Rutkowski A; Sparks S; Bonnemann C; Hegde M
    PLoS One; 2013; 8(1):e53083. PubMed ID: 23326386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetic analysis of PKHD1 by next-generation sequencing in Czech families with autosomal recessive polycystic kidney disease.
    Obeidova L; Seeman T; Elisakova V; Reiterova J; Puchmajerova A; Stekrova J
    BMC Med Genet; 2015 Dec; 16():116. PubMed ID: 26695994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial and nuclear disease panel (Mito-aND-Panel): Combined sequencing of mitochondrial and nuclear DNA by a cost-effective and sensitive NGS-based method.
    Abicht A; Scharf F; Kleinle S; Schön U; Holinski-Feder E; Horvath R; Benet-Pagès A; Diebold I
    Mol Genet Genomic Med; 2018 Nov; 6(6):1188-1198. PubMed ID: 30406974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Evaluation of Sanger Validation of Next-Generation Sequencing Variants.
    Beck TF; Mullikin JC; ; Biesecker LG
    Clin Chem; 2016 Apr; 62(4):647-54. PubMed ID: 26847218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted next-generation sequencing can replace Sanger sequencing in clinical diagnostics.
    Sikkema-Raddatz B; Johansson LF; de Boer EN; Almomani R; Boven LG; van den Berg MP; van Spaendonck-Zwarts KY; van Tintelen JP; Sijmons RH; Jongbloed JD; Sinke RJ
    Hum Mutat; 2013 Jul; 34(7):1035-42. PubMed ID: 23568810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance evaluation of the next-generation sequencing approach for molecular diagnosis of hereditary hearing loss.
    Sivakumaran TA; Husami A; Kissell D; Zhang W; Keddache M; Black AP; Tinkle BT; Greinwald JH; Zhang K
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):1007-16. PubMed ID: 23525850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of target enrichment platforms using massively parallel sequencing for the mutation detection for congenital muscular dystrophy.
    Valencia CA; Rhodenizer D; Bhide S; Chin E; Littlejohn MR; Keong LM; Rutkowski A; Bonnemann C; Hegde M
    J Mol Diagn; 2012; 14(3):233-46. PubMed ID: 22426012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.